Francis Anna, Cho Yeoungjee, Johnson David W
Department of Renal Medicine, Princess Alexandra Hospital, Brisbane, QLD 4102, Australia ; University of Sydney, Sydney, NSW 2006, Australia.
Department of Renal Medicine, Princess Alexandra Hospital, Brisbane, QLD 4102, Australia ; Centre for Kidney Disease Research, Translational Research Institute, University of Queensland, Brisbane, QLD 4102, Australia.
Evid Based Complement Alternat Med. 2015;2015:261425. doi: 10.1155/2015/261425. Epub 2015 Jun 17.
Infection is a major cause of morbidity and mortality at all stages of chronic kidney disease (CKD). Multiresistant organisms are becoming increasingly common, particularly in the CKD population. Unfortunately, the rapid evolution of antibiotic resistance has not been mirrored by innovation in new antibiotic agents. Novel treatments are therefore urgently needed. Honey has garnered much interest due to its broad-spectrum antibacterial properties based on extensive experimental data. Unlike conventional antibiotics, honey has an added advantage as it appears to avoid inducing antimicrobial resistance in bacteria. This review discusses the potential mechanisms of action and role of honey in infection management in the general population, epidemiology and special challenges of infections in CKD populations, and the clinical trial evidence pertaining to the safety and efficacy of honey for the prevention and treatment of infections in CKD population.
感染是慢性肾脏病(CKD)各个阶段发病和死亡的主要原因。多重耐药菌越来越常见,尤其是在CKD人群中。不幸的是,抗生素耐药性的快速演变并未伴随着新型抗生素药物的创新。因此,迫切需要新的治疗方法。基于大量实验数据,蜂蜜因其广谱抗菌特性而备受关注。与传统抗生素不同,蜂蜜具有额外的优势,因为它似乎不会诱导细菌产生抗药性。本文综述了蜂蜜在普通人群感染管理中的潜在作用机制和作用、CKD人群感染的流行病学及特殊挑战,以及蜂蜜预防和治疗CKD人群感染的安全性和有效性的临床试验证据。